Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenretinide in Recurrent and Metastatic Head and Neck Cancer
NCT00006471Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Sep 2000
- Primary completion
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fenretinide in squamous cell carcinoma of the head and neck (HNSCC), sponsored by University of Texas MD Anderson Cancer Center. Started Sep 2000; status: completed.
02
Drugs
fenretinide
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00006471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006471.